American Healthcare REIT (AHR) Stock Forecast, Price Target & Predictions
AHR Stock Forecast
American Healthcare REIT (AHR) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $28.50, with a high of $29.00 and a low of $28.00. This represents a 0.18% increase from the last price of $28.45.
AHR Stock Rating
American Healthcare REIT stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
AHR Forecast vs Benchmarks
Type | Name | Upside |
---|---|---|
Stock | American Healthcare REIT | 0.18% |
Sector | Real Estate Stocks | 14.90% |
Industry | Healthcare REIT Stocks | 10.70% |
Price Target Trends
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 7 |
Avg Price Target | - | $29.00 | $23.71 |
Last Closing Price | $28.45 | $28.45 | $28.45 |
Upside/Downside | - | 1.93% | -16.66% |
Ratings Trends
Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
---|---|---|---|---|---|---|
Jan, 25 | 4 | 3 | 1 | - | - | 8 |
Dec, 24 | 4 | 3 | 1 | - | - | 8 |
Nov, 24 | 4 | 5 | 1 | - | - | 10 |
Oct, 24 | 4 | 5 | 2 | - | - | 11 |
Sep, 24 | 4 | 5 | 2 | - | - | 11 |
Latest Price Target by Analysts
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 15, 2024 | Michael Lewis | Truist Financial | $29.00 | $26.51 | 9.39% | 1.93% |
Sep 20, 2024 | Michael Lewis | Truist Financial | $27.00 | $25.85 | 4.45% | -5.10% |
Sep 20, 2024 | Austin Wurschmidt | KeyBanc | $28.00 | $25.67 | 9.08% | -1.58% |
Sep 16, 2024 | Austin Wurschmidt | KeyBanc | $27.00 | $24.58 | 9.85% | -5.10% |
Sep 03, 2024 | Michael Lewis | Truist Financial | $22.00 | $20.93 | 5.11% | -22.67% |
Jun 28, 2024 | Michael Lewis | Truist Financial | $17.00 | $14.61 | 16.36% | -40.25% |
Apr 03, 2024 | Michael Lewis | Truist Financial | $16.00 | $14.10 | 13.48% | -43.76% |
Latest Upgrade/Downgrade by Analysts
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 30, 2024 | Morgan Stanley | Overweight | Overweight | hold |
Sep 20, 2024 | JMP Securities | Outperform | Outperform | hold |
Sep 16, 2024 | KeyBanc | Overweight | Overweight | hold |
Aug 22, 2024 | Morgan Stanley | Overweight | Overweight | hold |
Aug 07, 2024 | JMP Securities | Outperform | Outperform | hold |
May 16, 2024 | Truist Financial | Market Outperform | Market Outperform | hold |
Apr 03, 2024 | RBC Capital | Underperform | Underperform | hold |
Mar 04, 2024 | RBC Capital | Outperform | initialise |
Financial Forecast
EPS Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $-1.15 | - | - | - | - | - |
Avg Forecast | $-1.00 | $0.06 | $0.40 | $0.64 | - | - |
High Forecast | $-1.02 | $0.06 | $0.39 | $0.55 | - | - |
Low Forecast | $-0.95 | $0.06 | $0.42 | $0.69 | - | - |
Surprise % | 15.00% | - | - | - | - | - |
Revenue Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $1.88B | - | - | - | - | - |
Avg Forecast | $1.85B | $2.01B | $2.23B | $2.38B | $2.82B | $3.00B |
High Forecast | $1.67B | $1.81B | $2.01B | $2.36B | $2.54B | $2.70B |
Low Forecast | $1.86B | $2.14B | $2.37B | $2.39B | $3.00B | $3.19B |
Surprise % | 1.26% | - | - | - | - | - |
Net Income Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $-76.22M | - | - | - | - | - |
Avg Forecast | $-65.28M | $4.20M | $26.88M | $40.92M | - | - |
High Forecast | $-67.58M | $4.15M | $25.85M | $36.46M | - | - |
Low Forecast | $-62.98M | $4.24M | $27.91M | $45.37M | - | - |
Surprise % | 16.77% | - | - | - | - | - |